EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts

Andrea Galeazzo Rigutini iD, Tommaso Bucci iD, Amir Askarinejad iD, Enrico Tartaglia, Michele Rossi, Cecilia Becattini, Giuseppe Boriani, Hung-Fat Tse iD, Tze-Fan Chao iD, Gregory Y H Lip iD

European Journal of Clinical Investigation · 2026-04 · 56 (4)

DOI: 10.1111/eci.70205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 18.04.2026. Verfasst von Andrea Galeazzo Rigutini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverp…. Hauptthemen laut MEDLINE: Anemia, Anticoagulants, Atrial Fibrillation. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anaemia is a common comorbidity in patients with atrial fibrillation (AF) receiving oral anticoagulants (OACs). While its relationship with bleeding is well established, the prothrombotic role and ethnic variations remain unclear.

Methods

We analysed two large prospective AF registries from Europe (EORP‐AF) and East Asia (APHRS‐AF). Patients were classified by anaemia status at enrolment. Logistic regression assessed clinical correlates and treatment patterns, while multivariable Cox models and propensity score matching (PSM) evaluated outcomes. Restricted cubic spline analyses explored the haemoglobin–risk relationship across ethnic groups. The primary outcome was a composite of all‐cause death and major adverse cardiovascular events (MACE); secondary outcomes included individual components and major bleeding (MB).

Results

Among 10,857 patients with AF (mean age 69 ± 11 years, 40.0% women), 3372 (31.0%) had anaemia, which clustered with multimorbidity and frailty. Anaemic patients were less likely to receive OACs (OR 0.67, 95% CI 0.58–0.78) and rhythm‐control (OR 0.91, 95% CI 0.81–1.02). Anaemia was independently associated with higher risk of the composite outcome (HR 1.54, 95% CI 1.34–1.78), all‐cause death (HR 1.81, 95% CI 1.51–2.15), MACE (HR 1.39, 95% CI 1.16–1.66), CV death (HR 1.90, 95% CI 1.43–2.54) and MB (HR 1.79, 95% CI 1.31–2.46) consistent also after PSM. Risk increased progressively with anaemia severity, particularly below 10 g/dL. Associations were consistent across Asian and European cohorts.

Conclusion

Anaemia identifies a vulnerable AF phenotype associated with excess mortality, adverse cardiovascular outcomes and increased bleeding risk, which remains frequently undertreated. Risk rises with anaemia severity, and although biological effects appear consistent across ethnicities, treatment disparities persist. Anaemia should refine, not restrict, therapy within integrated AF care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnemiaAnticoagulantsAtrial FibrillationAgedFemaleHumansMaleMiddle AgedAsia, EasternCause of DeathEuropeHemorrhageLogistic ModelsPropensity ScoreProportional Hazards ModelsProspective StudiesRegistriesStroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
  • Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy.
  • Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, Italy University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Internal Medicine and Nephrology Division, ASL1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.
  • The University of Hong Kong, Hong Kong Special Administrative Region of China, Pok Fu Lam, Hong Kong.

ORCID-Profile: Andrea Galeazzo Rigutini, Tommaso Bucci, Amir Askarinejad, Hung-Fat Tse, Tze-Fan Chao, Gregory Y H Lip

Zitieren

APA

Rigutini, A. G., Bucci, T., Askarinejad, A., Tartaglia, E., Rossi, M., Becattini, C., Boriani, G., Tse, H. F., Chao, T. F., & Lip, G. Y. H. (2026). Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts. European Journal of Clinical Investigation, 56(4). https://doi.org/10.1111/eci.70205

Vancouver

Rigutini AG, Bucci T, Askarinejad A, Tartaglia E, Rossi M, Becattini C, et al. Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts. European Journal of Clinical Investigation. 2026;56(4). doi:10.1111/eci.70205

BibTeX
@article{Rigutini2026,
  author = {Rigutini, Andrea Galeazzo and Bucci, Tommaso and Askarinejad, Amir and Tartaglia, Enrico and Rossi, Michele and Becattini, Cecilia and Boriani, Giuseppe and Tse, Hung-Fat and Chao, Tze-Fan and Lip, Gregory Y H},
  title = {Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {4},
  doi = {10.1111/eci.70205}
}
Kostenlos starten →